Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05025670 · ClinicalTrials.gov registry record
Tracking Response in Advance of Investigational Trials, Borderline Study
A clinical trial, sponsored by Adams Clinical.
- Completed
- Registry status
- 28
- Enrollment target
NCT05025670 is a clinical trial that has completed, run by Adams Clinical. The registered enrollment target is 28 participants.
The verdict
NCT05025670 has completed, sponsored by Adams Clinical.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to more infrequent, short term, or longer term supportive psychotherapy.
Interventions
- BEHAVIORAL Supportive psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2022-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05025670
The ClinicalTrials.gov registry entry for NCT05025670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adams Clinical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Supportive psychotherapy is the first listed.
NCT05025670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05025670 about?
NCT05025670 is a clinical study titled "Tracking Response in Advance of Investigational Trials, Borderline Study". TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to mo...
What is the current status of trial NCT05025670?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-08-05. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05025670?
The interventions under investigation include: Supportive psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05025670?
This trial is sponsored by Adams Clinical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.